Esmé Waanders

Utrecht University — Netherlands

Medicine · Health Sciences

31h-index3.6kcitations136works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(71), Cancer Genomics and Diagnostics(25), Genomics and Rare Diseases(17), Chronic Myeloid Leukemia Treatments(15), Acute Myeloid Leukemia Research(14)

Publications136 total

Supplementary Figures S1-S6 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2025Open Access
Supplementary Table S2 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2025Open Access
Supplementary Table S3 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2025Open Access
Supplementary Table S1 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2025Open Access
IMPROVED DISEASE FREE SURVIVAL IN JMML. THE DUTCH EXPERIENCE.
EJC Paediatric Oncology·2025Open Access
ADVANCED MYELODYSPLASTIC SYNDROME. THE DUTCH EXPERIENCE.
EJC Paediatric Oncology·2025Open Access
Rapid DNA-methylation based classification of hematological malignancies
Blood·2025Open Access
NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis
Blood·2025Open Access
Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants
Genetics in Medicine·2025Open Access
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325]
European Journal of Cancer·2025· 1 citedOpen Access
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL
JCO Precision Oncology·2025· 9 citedOpen Access
Supplementary Figures S1-S6 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2024Open Access
Data from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2024Open Access
Supplementary Table S3 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2024Open Access
Supplementary Table S1 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2024Open Access
Supplementary Table S2 from Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
2024Open Access
Challenging Conventional Diagnostic Methods By Comprehensive Molecular Diagnostics: Results of a Nationwide Prospective Comparison in Children with Acute Lymphoblastic Leukemia
Blood·2024
Data from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
2024Open Access
Supplementary Tables from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
2024Open Access
Supplementary Note from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Roland P. Kuiper(29), Peter M. Hoogerbrugge(18), Frank N. van Leeuwen(14), Edwin Sonneveld(13), Marjolijn C.J. Jongmans(13), Simon V. van Reijmersdal(11), Ad Geurts van Kessel(11), Charles G. Mullighan(10), Joost P.H. Drenth(8), Jinghui Zhang(7), Rob Pieters(7), Vincent H. J. van der Velden(7), Michael Rusch(6), Guangchun Song(6), Rosemary Sutton(6), Kathryn G. Roberts(6), Debbie Payne-Turner(6), Xiaotu Ma(6), John E. Dick(6), Blanca Scheijen(6)